跳至主要内容
临床试验/CTRI/2020/12/030114
CTRI/2020/12/030114尚未招募未知

â??Evaluation Of VEGF Expression Of Tumor Cells As a Potential Prognostic Marker In Ewingâ??s Sarcomaâ??. - VEGF

Roche Products India Private Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Histological proven, Ewingâ??s sarcoma patients, who were
  • 1.Non-metastatic
  • 2.All ages
  • 3.Both osseous and non osseous
  • 4.Treatment naïve
  • 5.Treated uniformly on EFT 2001 protocol and underwent surgery as local treatment at TMH between 2010-2012 and with a minimum follow up of 6 months

排除标准

  • 1. Prior treatment (chemotherapy, radiotherapy or surgery)
  • 2. Metastatic disease at presentation
  • 3. Pathologically inadequate specimens
  • 4. Radiotherapy as definitive local treatment

研究者

相似试验